Patent · US Active

Compositions and methods for safe treatment of rhinitis

US10201594B2 · kind B2 · utility

11Cited by
68References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 16, 2016
Grant dateFeb 12, 2019
Priority date
Expiry dateMay 16, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y304/24069
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods for treating rhinitis in a subject are provided herein. The methods of the present invention comprise intranasal administration of a topical composition comprising a purified botulinum neurotoxin, a carrier and a viscosity modifier to one or more inner surfaces of the nose. The methods disclosed herein provide alternative methods for delivery of botulinum neurotoxin to the nasal anatomy for the treatment of rhinitis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.